Literature DB >> 6425196

The use of fructose 1-phosphate to detect Hunter heterozygotes in fibroblast cultures from high-risk carriers.

T Tønnesen.   

Abstract

Fibroblast cultures from 49 possible Hunter disease carriers were collected. These cultures were analysed for the incorporation of 35S-sulphate into acid mucopolysaccharides in the presence and the absence of fructose 1-phosphate. For 10 of these women more than one abnormal result was observed, when two or three cultures from each individual were tested. For six additional women only one abnormal result was found, when three cultures for each of these females were analysed. The implication that just one abnormal result indicates carriership stems from the observation that 24 out of 25 obligate carriers have been confirmed by this criterion (Tønnesen et al. 1983). By mean of the same criterion we have thus established carriership for 16 possible carriers. From genetic inference three additional carriers were found among the females showing normal results in the fibroblast cultures. As a test of the reliability of the method, analyses of the tested informative female offspring of Hunter carriers showed 20 of 38 informative females to be carriers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425196     DOI: 10.1007/bf00286603

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Carrier detection in Duchenne muscular dystrophy.

Authors:  A D Roses; M J Roses; S E Miller; K L Hull; S H Appel
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

Review 2.  X-chromosome inactivation and developmental patterns in mammals.

Authors:  M F Lyon
Journal:  Biol Rev Camb Philos Soc       Date:  1972-01

3.  The defect in Hurler's and Hunter's syndromes: faulty degradation of mucopolysaccharide.

Authors:  J C Fratantoni; C W Hall; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1968-06       Impact factor: 11.205

4.  The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation.

Authors:  J C Fratantoni; C W Hall; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

5.  Reliability of the Tønnesen technique for the identification of Hunter carriers.

Authors:  L Petruschka; G Machill; M Wehnert; G Seidlitz; A Knapp
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  X-linked Hunter syndrome: the heterozygous phenotype in cell culture.

Authors:  B R Migeon; J A Sprenkle; I Liebaers; J F Scott; E F Neufeld
Journal:  Am J Hum Genet       Date:  1977-09       Impact factor: 11.025

7.  The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease.

Authors:  U Francke; J Felsenstein; S M Gartler; B R Migeon; J Dancis; J E Seegmiller; F Bakay; W L Nyhan
Journal:  Am J Hum Genet       Date:  1976-03       Impact factor: 11.025

8.  Reliability of the use of fructose 1-phosphate to detect Hunter cells in fibroblast-cultures of obligate carriers of the Hunter syndrome.

Authors:  T Tønnesen; F Güttler; C Lykkelund
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  Diagnosis of Hunter's syndrome carriers; radioactive sulphate incorporation into fibroblasts in the presence or fructose 1-phosphate.

Authors:  T Tønnesen; C Lykkelund; F Güttler
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

10.  Hurler's syndrome: a genetic study of clones in cell culture with particular reference to the Lyon hypothesis.

Authors:  B S Danes; A G Bearn
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

  10 in total
  6 in total

1.  Segregation and sporadic cases in families with Hunter's syndrome.

Authors:  G Machill; G Barbujani; G A Danieli; F H Herrmann
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

2.  Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.

Authors:  K M Timms; F J Edwards; J W Belmont; J R Yates; R A Gibbs
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

3.  Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.

Authors:  W Schröder; L Petruschka; M Wehnert; M Zschiesche; G Seidlitz; J J Hopwood; F H Herrmann
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

4.  Clinical and biochemical studies in mucopolysaccharidosis type II carriers.

Authors:  I V D Schwartz; L L C Pinto; G Breda; L Lima; M G Ribeiro; J G Mota; A X Acosta; P Correia; D D G Horovitz; C G G Porciuncula; E Lipinski-Figueiredo; A C Fett-Conte; R P Oliveira Sobrinho; D Y J Norato; A C Paula; C A Kim; A R Duarte; R Boy; S Leistner-Segal; M G Burin; R Giugliani
Journal:  J Inherit Metab Dis       Date:  2009-10-10       Impact factor: 4.982

5.  Hunter syndrome among Ashkenazi Jews in Israel; evidence for prenatal selection favoring the Hunter allele.

Authors:  J Zlotogora; T Schaap; M Zeigler; G Bach
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Normal excretion of urinary acid mucopolysaccharides in a boy with iduronate sulphatase deficiency, Hunter phenotype and alpha 1-antitrypsin deficiency.

Authors:  J B Nielsen; F Güttler; N Hobolth; T Tønnesen; O D Pedersen; C Lykkelund; F Rosleff
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.